Iodothyronine polymers
Patent 5767227 Issued on June 16, 1998. Estimated Expiration Date: 
June 16, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
June 16, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesIodothyronine enzyme conjugates Iodothyronine immunogens and antibodies Patent #: 4399121 InventorsAssigneeApplicationNo. 347104 filed on 11/22/1994US Classes:530/324, 25 or more amino acid residues in defined sequence424/78.08, SOLID SYNTHETIC ORGANIC POLYMER AS DESIGNATED ORGANIC ACTIVE INGREDIENT (DOAI)514/5, Iodine containing514/12, 25 or more peptide repeating units in known peptide chain structure514/13, 16 to 24 peptide repeating units in known peptide chain514/14, 12 to 15 peptide repeating units in known peptide chain514/15, 9 to 11 peptide repeating units in known peptide chain514/16, 7 or 8 peptide repeating units in known peptide chain514/17, 5 or 6 peptide repeating units in known peptide chain530/325, 24 amino acid residues in defined sequence530/326, 15 to 23 amino acid residues in defined sequence530/327, 11 to 14 amino acid residues in defined sequence530/328, 8 to 10 amino acid residues in defined sequence530/329, 6 to 7 amino acid residues in defined sequence530/3304 to 5 amino acid residues in defined sequenceExaminersPrimary: Tsang, Cecilia J.Assistant: Lukton, David Attorney, Agent or FirmInternational ClassesA61K 038/16A61K 031/74 AbstractIodothyronine polymers having a plurality of recurring units of formula I ##STR1## in which A is iodo and B, C and D are independently H or iodo are described. Polymers in which A and C are iodo and B and D are independently H or iodo and in which substantially all of the recurring units are L-stereoisomers, have utility in treating thyroid hormone deficiencies.Field of SearchIodine containing25 or more peptide repeating units in known peptide chain structure 16 to 24 peptide repeating units in known peptide chain 12 to 15 peptide repeating units in known peptide chain 9 to 11 peptide repeating units in known peptide chain 7 or 8 peptide repeating units in known peptide chain 5 or 6 peptide repeating units in known peptide chain SOLID SYNTHETIC ORGANIC POLYMER AS DESIGNATED ORGANIC ACTIVE INGREDIENT (DOAI) 24 amino acid residues in defined sequence 25 or more amino acid residues in defined sequence 15 to 23 amino acid residues in defined sequence 11 to 14 amino acid residues in defined sequence 8 to 10 amino acid residues in defined sequence |
| ||||||||||||||
